{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:28:31Z","timestamp":1791293311755,"version":"4.1.0"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":577,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Nonalcoholic fatty liver disease (NAFLD), hepatic insulin resistance, and type 2 diabetes are all strongly associated and are all reaching epidemic proportions. Whether there is a causal link between NAFLD and hepatic insulin resistance is controversial. This review will discuss recent studies in both humans and animal models of NAFLD that have implicated increases in hepatic diacylglycerol (DAG) content leading to activation of novel protein kinase C\u03b5 (PKC\u03b5) resulting in decreased insulin signaling in the pathogenesis of NAFLD-associated hepatic insulin resistance and type 2 diabetes. The DAG-PKC\u03b5 hypothesis can explain the occurrence of hepatic insulin resistance observed in most cases of NAFLD associated with obesity, lipodystrophy, and type 2 diabetes. (Hepatology 2014;59:713\u2013723)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26672","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T15:21:58Z","timestamp":1375975318000},"page":"713-723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":663,"title":["Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes"],"prefix":"10.1097","volume":"59","author":[{"given":"Andreas L.","family":"Birkenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald I.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-38-20250207","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights.","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"R3-38-20250207","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"R4-38-20250207","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.2337\/db11-0231","article-title":"The metabolically benign and malignant fatty liver.","volume":"60","author":"Stefan","year":"2011","journal-title":"Diabetes"},{"key":"R5-38-20250207","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance.","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab"},{"key":"R7-38-20250207","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.24170","article-title":"Regulation of hepatic fat and glucose oxidation in rats with lipidinduced hepatic insulin resistance.","volume":"53","author":"Alves","year":"2011","journal-title":"Hepatology"},{"key":"R8-38-20250207","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipidinduced insulin resistance: unravelling the mechanism.","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"R9-38-20250207","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance.","volume":"106","author":"Shulman","year":"2000","journal-title":"J Clin Invest"},{"key":"R10-38-20250207","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MED.0b013e3283293015","article-title":"Nonalcoholic fatty liver disease in type 2 diabetes mellitus.","volume":"16","author":"Cusi","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R11-38-20250207","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s001250051123","article-title":"Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.","volume":"42","author":"Krssak","year":"1999","journal-title":"Diabetologia"},{"key":"R12-38-20250207","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/er.2008-0009","article-title":"Causes and metabolic consequences of fatty liver.","volume":"29","author":"Stefan","year":"2008","journal-title":"Endocr Rev"},{"key":"R13-38-20250207","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","article-title":"Effects of free fatty acids on glucose transport and IRS1associated phosphatidylinositol 3kinase activity.","volume":"103","author":"Dresner","year":"1999","journal-title":"J Clin Invest"},{"key":"R14-38-20250207","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipidinduced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaBalpha.","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"R15-38-20250207","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-38-20250207","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in nonalcoholic fatty liver disease.","volume":"279","author":"Samuel","year":"2004","journal-title":"J Biol Chem"},{"key":"R18-38-20250207","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.","volume":"117","author":"Samuel","year":"2007","journal-title":"J Clin Invest"},{"key":"R19-38-20250207","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1007\/s00125-009-1543-0","article-title":"Diverse roles for protein kinase C delta and protein kinase C epsilon in the generation of highfatdietinduced glucose intolerance in mice: regulation of lipogenesis by protein kinase C delta.","volume":"52","author":"Frangioudakis","year":"2009","journal-title":"Diabetologia"},{"key":"R20-38-20250207","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2005.06.006","article-title":"Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acylCoA:glycerolsn3phosphate acyltransferase 1 knockout mice.","volume":"2","author":"Neschen","year":"2005","journal-title":"Cell Metab"},{"key":"R22-38-20250207","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1073\/pnas.1103451108","article-title":"Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2.","volume":"108","author":"Jornayvaz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-38-20250207","doi-asserted-by":"crossref","first-page":"22678","DOI":"10.1074\/jbc.M704213200","article-title":"Suppression of diacylglycerol acyltransferase2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses dietinduced hepatic steatosis and insulin resistance.","volume":"282","author":"Choi","year":"2007","journal-title":"J Biol Chem"},{"key":"R24-38-20250207","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1074\/jbc.M111.304907","article-title":"Fatty acidbinding proteins transport Nacylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors.","volume":"287","author":"Kaczocha","year":"2012","journal-title":"J Biol Chem"},{"key":"R25-38-20250207","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1194\/jlr.M020966","article-title":"Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged LFabp mice.","volume":"53","author":"Newberry","year":"2012","journal-title":"J Lipid Res"},{"key":"R27-38-20250207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid1 receptor inverse agonism reduces obesity by reversing leptin resistance.","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metab"},{"key":"R28-38-20250207","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab"},{"key":"R29-38-20250207","doi-asserted-by":"crossref","first-page":"38041","DOI":"10.1074\/jbc.M112.377978","article-title":"Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMPresponse elementbinding protein H (Crebh)mediated induction of Lipin1 gene.","volume":"287","author":"Chanda","year":"2012","journal-title":"J Biol Chem"},{"key":"R30-38-20250207","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB1 receptors by stellate cellderived endocannabinoids mediates alcoholic fatty liver.","volume":"7","author":"Jeong","year":"2008","journal-title":"Cell Metab"},{"key":"R31-38-20250207","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cmet.2011.06.009","article-title":"Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice.","volume":"14","author":"Birkenfeld","year":"2011","journal-title":"Cell Metab"},{"key":"R32-38-20250207","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cmet.2009.10.007","article-title":"Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response elementbinding protein.","volume":"10","author":"Erion","year":"2009","journal-title":"Cell Metab"},{"key":"R33-38-20250207","doi-asserted-by":"crossref","first-page":"E808E815","DOI":"10.1152\/ajpendo.00361.2010","article-title":"A highfat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain.","volume":"299","author":"Jornayvaz","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R34-38-20250207","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.24571","article-title":"Apolipoprotein CIII overexpressing mice are predisposed to dietinduced hepatic steatosis and hepatic insulin resistance.","volume":"54","author":"Lee","year":"2011","journal-title":"Hepatology"},{"key":"R35-38-20250207","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2337\/db10-1328","article-title":"SGLT2 deletion improves glucose homeostasis and preserves pancreatic betacell function.","volume":"60","author":"Jurczak","year":"2011","journal-title":"Diabetes"},{"key":"R36-38-20250207","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/hep.26170","article-title":"Role of patatinlike phospholipase domaincontaining 3 on lipidinduced hepatic steatosis and insulin resistance in rats.","volume":"57","author":"Kumashiro","year":"2013","journal-title":"Hepatology"},{"key":"R37-38-20250207","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1073\/pnas.1212887109","article-title":"Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism.","volume":"109","author":"Brown","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-38-20250207","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2337\/db12-1311","article-title":"Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance.","volume":"62","author":"Kumashiro","year":"2013","journal-title":"Diabetes"},{"key":"R39-38-20250207","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"R40-38-20250207","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/00365527709181339","article-title":"Liver histology in a normal populationexaminations of 503 consecutive fatal traffic casualties.","volume":"12","author":"Hilden","year":"1977","journal-title":"Scand J Gastroenterol"},{"key":"R41-38-20250207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1381\/096089202321144577","article-title":"Liver pathology in morbidly obese patients undergoing RouxenY gastric bypass surgery.","volume":"12","author":"Gholam","year":"2002","journal-title":"Obes Surg"},{"key":"R42-38-20250207","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.24242","article-title":"Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects.","volume":"53","author":"Haufe","year":"2011","journal-title":"Hepatology"},{"key":"R44-38-20250207","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease.","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"issue":"Suppl","key":"R45-38-20250207","first-page":"S86S90","article-title":"Regulation of fatty acid uptake into tissues: lipoprotein lipase and CD36mediated pathways.","volume":"50","author":"Goldberg","year":"2009","journal-title":"J Lipid Res"},{"key":"R46-38-20250207","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1210\/jcem-59-6-1176","article-title":"Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity.","volume":"59","author":"Sadur","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-38-20250207","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocytemacrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulinresistant subjects.","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"R48-38-20250207","doi-asserted-by":"crossref","first-page":"G1281G1287","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD.","volume":"294","author":"Greco","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R49-38-20250207","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-38-20250207","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.121164498","article-title":"Tissuespecific overexpression of lipoprotein lipase causes tissuespecific insulin resistance.","volume":"98","author":"Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-38-20250207","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1172\/JCI2912","article-title":"Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia.","volume":"102","author":"Merkel","year":"1998","journal-title":"J Clin Invest"},{"key":"R52-38-20250207","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-0907","article-title":"Increased hepatic CD36 expression contributes to dyslipidemia associated with dietinduced obesity.","volume":"56","author":"Koonen","year":"2007","journal-title":"Diabetes"},{"key":"R53-38-20250207","doi-asserted-by":"crossref","first-page":"E384E393","DOI":"10.1152\/ajpendo.00226.2010","article-title":"FATP2 is a hepatic fatty acid transporter and peroxisomal very longchain acylCoA synthetase.","volume":"299","author":"Falcon","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R54-38-20250207","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","article-title":"Mechanism of insulin resistance in AZIPF1 fatless mice.","volume":"275","author":"Kim","year":"2000","journal-title":"J Biol Chem"},{"key":"R55-38-20250207","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"R56-38-20250207","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"R57-38-20250207","doi-asserted-by":"crossref","first-page":"40409","DOI":"10.1074\/jbc.R110.182451","article-title":"Endogenous ligands for nuclear receptors: digging deeper.","volume":"285","author":"Schupp","year":"2010","journal-title":"J Biol Chem"},{"key":"R58-38-20250207","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominantnegative mutations in the nuclear receptor peroxisome proliferatoractivated receptorgamma.","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"R59-38-20250207","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liverspecific disruption of PPARgamma in leptindeficient mice improves fatty liver but aggravates diabetic phenotypes.","volume":"111","author":"Matsusue","year":"2003","journal-title":"J Clin Invest"},{"key":"R60-38-20250207","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferatoractivated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J Biol Chem"},{"key":"R61-38-20250207","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","article-title":"The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.","volume":"51","author":"Mayerson","year":"2002","journal-title":"Diabetes"},{"key":"R62-38-20250207","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/jc.2009-0911","article-title":"Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus.","volume":"95","author":"Bajaj","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-38-20250207","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0031-1301284","article-title":"Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.","volume":"44","author":"Luedtke","year":"2012","journal-title":"Horm Metab Res"},{"key":"R64-38-20250207","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI8305","article-title":"Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle.","volume":"105","author":"Kim","year":"2000","journal-title":"J Clin Invest"},{"key":"R65-38-20250207","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI200421341","article-title":"GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.","volume":"114","author":"Kotani","year":"2004","journal-title":"J Clin Invest"},{"key":"R66-38-20250207","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1073\/pnas.0705408104","article-title":"The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.","volume":"104","author":"Petersen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R67-38-20250207","doi-asserted-by":"crossref","first-page":"13705","DOI":"10.1073\/pnas.1110105108","article-title":"Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals.","volume":"108","author":"Rabol","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R68-38-20250207","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/db09-1200","article-title":"Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content.","volume":"59","author":"Haufe","year":"2010","journal-title":"Diabetes"},{"key":"R69-38-20250207","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.25548","article-title":"Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.","volume":"55","author":"Sullivan","year":"2012","journal-title":"Hepatology"},{"key":"R70-38-20250207","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118324","article-title":"Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.","volume":"96","author":"Li","year":"1995","journal-title":"J Clin Invest"},{"key":"R71-38-20250207","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.","volume":"362","author":"Petersen","year":"2010","journal-title":"N Engl J Med"},{"key":"R72-38-20250207","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jhep.2011.03.035","article-title":"The APOC3 T455C and C482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.","volume":"55","author":"Valenti","year":"2011","journal-title":"J Hepatol"},{"key":"R73-38-20250207","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1440-1746.2011.07045.x","article-title":"Genetic variation in PNPLA3 but not APOC3 influences liver fat in nonalcoholic fatty liver disease.","volume":"27","author":"Hyysalo","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R74-38-20250207","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1515\/cclm.2011.747","article-title":"Gender and obesityspecific effect of apolipoprotein C3 gene (APOC3) 482CT polymorphism on triglyceride concentration in Turkish adults.","volume":"50","author":"Coban","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"R75-38-20250207","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ijo.2011.154","article-title":"Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.","volume":"36","author":"Peter","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"R76-38-20250207","doi-asserted-by":"crossref","first-page":"34998","DOI":"10.1074\/jbc.M111.278853","article-title":"Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator ABhydrolasecontaining 5 (ABHD5).","volume":"286","author":"Gandotra","year":"2011","journal-title":"J Biol Chem"},{"key":"R77-38-20250207","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy.","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"key":"R78-38-20250207","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2013.02.010","article-title":"Transcriptional cofactor TBLR1 controls lipid mobilization in white adipose tissue.","volume":"17","author":"Rohm","year":"2013","journal-title":"Cell Metab"},{"key":"R79-38-20250207","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1371\/journal.pone.0000569","article-title":"Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents.","volume":"2","author":"Liska","year":"2007","journal-title":"PLoS One"},{"key":"R80-38-20250207","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"R81-38-20250207","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatinlike phospholipase 3 gene.","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"key":"R82-38-20250207","doi-asserted-by":"crossref","first-page":"48968","DOI":"10.1074\/jbc.M407841200","article-title":"Identification, cloning, expression, and purification of three novel human calciumindependent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.","volume":"279","author":"Jenkins","year":"2004","journal-title":"J Biol Chem"},{"key":"R83-38-20250207","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"key":"R84-38-20250207","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/hep.24402","article-title":"Mouse patatinlike phospholipase domaincontaining 3 influences systemic lipid and glucose homeostasis.","volume":"54","author":"Qiao","year":"2011","journal-title":"Hepatology"},{"key":"R85-38-20250207","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.","volume":"52","author":"Basantani","year":"2011","journal-title":"J Lipid Res"},{"key":"R86-38-20250207","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase.","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"key":"R87-38-20250207","doi-asserted-by":"crossref","first-page":"47066","DOI":"10.1074\/jbc.M403855200","article-title":"Desnutrin, an adipocyte gene encoding a novel patatin domaincontaining protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis.","volume":"279","author":"Villena","year":"2004","journal-title":"J Biol Chem"},{"key":"R88-38-20250207","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1123965","article-title":"Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.","volume":"312","author":"Haemmerle","year":"2006","journal-title":"Science"},{"key":"R89-38-20250207","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.24338","article-title":"Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.","volume":"54","author":"Wu","year":"2011","journal-title":"Hepatology"},{"key":"R90-38-20250207","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00125-010-1895-5","article-title":"Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice.","volume":"54","author":"Turpin","year":"2011","journal-title":"Diabetologia"},{"key":"R91-38-20250207","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1073\/pnas.1219456110","article-title":"CGI58 knockdown sequesters diacylglycerols in lipid dropletsERpreventing diacylglycerolmediated hepatic insulin resistance.","volume":"110","author":"Cantley","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R92-38-20250207","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A ceramidecentric view of insulin resistance.","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab"},{"key":"R93-38-20250207","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1073\/pnas.1311176110","article-title":"Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR4 signaling and ceramide synthesis in vivo.","volume":"110","author":"Galbo","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R94-38-20250207","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","article-title":"The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling.","volume":"15","author":"Fu","year":"2012","journal-title":"Cell Metab"},{"key":"R95-38-20250207","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation.","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"R96-38-20250207","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1074\/jbc.M111.316760","article-title":"Dissociation of inositolrequiring enzyme (IRE1alpha)mediated cJun Nterminal kinase activation from hepatic insulin resistance in conditional Xboxbinding protein1 (XBP1) knockout mice.","volume":"287","author":"Jurczak","year":"2012","journal-title":"J Biol Chem"},{"key":"R97-38-20250207","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI37007","article-title":"GRP78 expression inhibits insulin and ER stressinduced SREBP1c activation and reduces hepatic steatosis in mice.","volume":"119","author":"Kammoun","year":"2009","journal-title":"J Clin Invest"},{"key":"R98-38-20250207","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmet.2008.04.011","article-title":"Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice.","volume":"7","author":"Oyadomari","year":"2008","journal-title":"Cell Metab"},{"key":"R99-38-20250207","doi-asserted-by":"crossref","first-page":"36163","DOI":"10.1074\/jbc.M111.228817","article-title":"Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulinmediated ER stress and hepatic and peripheral glucose metabolism.","volume":"286","author":"Birkenfeld","year":"2011","journal-title":"J Biol Chem"},{"key":"R100-38-20250207","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factoralpha: direct role in obesitylinked insulin resistance.","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"R102-38-20250207","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"R103-38-20250207","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1126\/science.1160794","article-title":"A stress signaling pathway in adipose tissue regulates hepatic insulin resistance.","volume":"322","author":"Sabio","year":"2008","journal-title":"Science"},{"key":"R104-38-20250207","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.23064","article-title":"Aggravation by prostaglandin E2 of interleukin6dependent insulin resistance in hepatocytes.","volume":"50","author":"Henkel","year":"2009","journal-title":"Hepatology"},{"key":"R105-38-20250207","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2009.09.007","article-title":"Prevention of steatosis by hepatic JNK1.","volume":"10","author":"Sabio","year":"2009","journal-title":"Cell Metab"},{"key":"R106-38-20250207","doi-asserted-by":"crossref","first-page":"22195","DOI":"10.1074\/jbc.M110.210237","article-title":"Loss of mitogenactivated protein kinase phosphatase1 protects from hepatic steatosis by repression of cell deathinducing DNA fragmentation factor A (DFFA)like effector C (CIDEC)fatspecific protein 27.","volume":"286","author":"Flach","year":"2011","journal-title":"J Biol Chem"},{"key":"R107-38-20250207","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2009.11.003","article-title":"Irs1 serine 307 promotes insulin sensitivity in mice.","volume":"11","author":"Copps","year":"2010","journal-title":"Cell Metab"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26672","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201402000-00038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:56:40Z","timestamp":1738947400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201402000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26672","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}